Table 3 Clinical characteristics between MACEs and non-MACEs
Variables | MACEs (n = 18) | non-MACEs (n = 141) | P value |
|---|---|---|---|
Male (n, %) | 13 (72.22%) | 122 (86.52%) | 0.139 |
Age (years) | 68.89 ± 8.99 | 62.23 ± 10.58 | 0.008 |
Current smoking (n, %) | 8 (44.44%) | 78 (52.48%) | 0.384 |
Hypertension (n, %) | 13 (72.22%) | 70 (49.64%) | 0.066 |
Hyperlipidemia (n, %) | 3 (16.67%) | 44 (31.20%) | 0.181 |
Diabetes (n, %) | 9 (50.00%) | 32 (22.69%) | 0.019 |
History of MI (n, %) | 3 (16.67%) | 18 (12.67%) | 0.655 |
STEMI (n, %) | 3 (16.67%) | 50 (35.40%) | 0.093 |
BMI (kg/m2) | 24.35 ± 2.55 | 33.85 ± 2.98 | 0.450 |
SBP on admission (mmHg) | 124.61 ± 17.44 | 128.84 ± 19.54 | 0.349 |
DBP on admission (mmHg) | 74.05 ± 13.76 | 75.83 ± 11.61 | 0.606 |
Glucose (mmol/L) | 7.06 ± 3.06 | 6.07 ± 1.76 | 0.192 |
Albumin (g/L) | 37.44 ± 4.30 | 39.84 ± 4.19 | 0.037 |
Triglycerides (mmol/L) | 1.21 ± 0.49 | 1.54 ± 0.80 | 0.021 |
Total cholesterol (mmol/L) | 3.77 ± 0.97 | 4.35 ± 0.99 | 0.030 |
HDL-C (mmol/L) | 0.92 ± 0.26 | 1.05 ± 0.27 | 0.068 |
LDL-C (mmol/L) | 2.45 ± 0.78 | 2.84 ± 0.88 | 0.061 |
Apo A (g/L) | 1.19 ± 0.95 | 1.14 ± 0.22 | 0.535 |
Apo B (g/L) | 0.87 ± 0.23 | 0.95 ± 0.25 | 0.146 |
Creatinine (umol/L) | 101.67 ± 46.63 | 79.88 ± 22.59 | 0.001 |
Fibrinogen (g/L) | 4.04 ± 0.86 | 4.24 ± 1.32 | 0.634 |
D-Dimer (mg/L) | 0.52 (0.36,1.48) | 0.42 (0.25,0.79) | 0.084 |
CTnI (ng/mL) | 8.44 (1.09,40.35) | 4.77 (1.02,28.74) | 0.518 |
NT-proBNP (pg/mL) | 1751 (372.00,9262.50) | 575 (248.00,1423.50) | 0.025 |
LVEF (%) | 0.51 ± 0.02 | 0.57 ± 0.01 | 0.006 |
Visfatin (ng/mL) | 9.89 (8.66,12.80) | 7.53 (6.53,8.94) | 0.001 |